Similar articles

• DNA repair by ERCC1 in non-small-cell lung cancer.

  Wilcox JE. Wilcox JE. N Engl J Med. 2006 Dec 14;355(24):2590; author reply 2591. N Engl J Med. 2006. PMID: 17171818 No abstract available.
• ERCC1 measurements in clinical oncology.

  Reed E. Reed E. N Engl J Med. 2006 Sep 7;355(10):1054-5. doi: 10.1056/NEJMe068162. N Engl J Med. 2006. PMID: 16957152 No abstract available.
• DNA repair by ERCC1 in non-small-cell lung cancer.

  Grenader T, Shavit L. Grenader T, et al. N Engl J Med. 2006 Dec 14;355(24):2591; author reply 2591. doi: 10.1056/NEJMc062750. N Engl J Med. 2006. PMID: 17167936 No abstract available.
• [Clinical advances in the chemotherapy of non-small cell lung cancer].

  Liao ML, Cheng BJ. Liao ML, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jul;27(7):480-2. Zhonghua Jie He He Hu Xi Za Zhi. 2004. PMID: 15312563 Review. Chinese. No abstract available.
• ERCC1 as a risk stratifier in platinum-based chemotherapy for nonsmall-cell lung cancer.

  Olaussen KA, Mountzios G, Soria JC. Olaussen KA, et al. Curr Opin Pulm Med. 2007 Jul;13(4):284-9. doi: 10.1097/MCP.0b013e32816b5c63. Curr Opin Pulm Med. 2007. PMID: 17534174 Review.